Shares of Bunge Global SA fell by more than 2% shortly before the market opened on Wednesday after short seller Spruce Point Management released a detailed forensic review calling for an independent investigation into the company's financial reporting and accounting practices.
In its report, Spruce Point describes the S&P 500-listed agribusiness as a complex roll-up that the short seller says has struggled to produce shareholder value without resorting to outside financing. The review sets out a series of financial assertions and strategic criticisms aimed squarely at Bunge's capital allocation and disclosures.
Among the report's specific claims, Spruce Point asserts that since 1999 Bunge has produced a cumulative cash flow deficit of $1.6 billion after accounting for capital expenditures, business investment and asset repositioning. During that same period, the short seller says the company distributed $4.7 billion in dividends and repurchased $3.9 billion of stock, actions the report contends were financed through additional debt.
Spruce Point singles out Bunge's oilseeds segment - historically its largest contributor to EBIT - as an area under mounting pressure. The short seller also notes that Bunge has not, according to its analysis, addressed the growing influence of GLP-1 weight loss drugs in its Securities and Exchange Commission filings or in public conference calls, despite the company serving customers in the packaged food sector.
Based on its review, Spruce Point estimates a potential downside range for Bunge shares of 55% to 80% and warns of material market underperformance risk. The report characterizes Bunge's $10.6 billion acquisition of Viterra from Glencore, announced in June 2023, as a transaction driven by necessity rather than strategic opportunity, and labels the deal as having substantially disappointed relative to expectations.
The short seller urged Bunge's board to open an investigation into matters related to the company's financial reporting and to provide greater clarity to investors. The report also raises concerns about new 2030 EPS guidance and signals the possibility of significant insider selling, warning that up to 30% of shares could be sold in the near term.
Bunge Global SA is incorporated in Geneva, Switzerland and is headquartered in St. Louis, Missouri. The company is an international exporter of soybeans and operates across food processing, grain trading and fertilizer businesses. Bunge shares have risen roughly 70% over the past 12 months, a performance figure noted in the report.
Context and next steps
Market reaction to the Spruce Point document was immediate, with the stock trading lower in pre-market activity. The short seller's demands for an independent probe, coupled with its financial calculations and strategic critique, present a direct challenge to management to address the allegations publicly and to clarify the assumptions behind its guidance and recent acquisitions.
At present, the report outlines its concerns and requests but does not itself change any filed financial statements or announced transactions. How Bunge responds, and whether its board will authorize the type of independent review Spruce Point seeks, remains to be seen.